Cart
sales@molnova.com
Zelminemab
CAS No. 2225850-33-7
Zelminemab( —— )
Catalog No. M36779 CAS No. 2225850-33-7
Zelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 603 | In Stock |
|
| 10MG | 1026 | In Stock |
|
| 25MG | 1501 | In Stock |
|
| 50MG | 2009 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZelminemab
-
NoteResearch use only, not for human use.
-
Brief DescriptionZelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
-
DescriptionZelminemab (AMG-301) is a human monoclonal antibody that inhibits PACAP type I (PAC1) receptor.
-
In Vitro——
-
In VivoAnimal Model:Sprague-Dawley rats, electricalstimulation was performed on the intact dura mater abovethe middle meningeal artery.Dosage:10 mg/kg Administration:i.v.; once Result:Induced an inhibition of stimulus-evoked nociceptive activity in the trigeminocervical com-plex (TCC).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225850-33-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Eloisa Rubio-Beltrán, et al. PACAP38 and PAC1 receptor blockade: a new target for headache? J Headache Pain. 2018 Aug 7;19(1):64. ?
molnova catalog
related products
-
Proteinase
Proteinases are enzymes that catalyse the breakdown of proteins. Proteinases are involved in many biological functions, including the digestion of ingested proteins, the breakdown of old proteins, and cell signalling.
-
Cyclic AMP
Adenosine cyclophosphate combined with vitamin C treatment of children with viral myocarditis has exact curative effect, and it can improve cardiac function of patients and improve immune function.
-
Lodoxamide ethyl
lodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.
